Category: wiley retractions

The Journal of Biochemical and Molecular Toxicology, a Wiley title, has corrected a pair of retraction notices in which “the reasons for the retraction were described inaccurately,” according to the corrections. The original notices also did not include “the authors’ disapproval of the retraction.” 

The retracted articles, “The cardioprotective effects of a combination of quercetin and α-tocopherol on isoproterenol-induced myocardial infarcted rats,” and “Protective effects of caffeic acid on lactate dehydrogenase isoenzymes, electrocardiogram, adenosine triphosphatases, and hematology on isoproterenol-induced myocardial infarcted rats,” both appeared in the same journal in 2011, but in different issues. They have been cited 35 times, collectively, according to Clarivate’s Web of Science. 

In 2020, Elisabeth Bik posted about the papers on PubPeer, pointing out figures in the articles, which have the same corresponding author, were “unexpectedly similar” to each other. “Note that the lanes represent very different experiments,” she wrote. 

A health services journal has retracted a recent commentary about diversity, equity and inclusion (DEI) activities at the University of Minnesota after the authors said they had unintentionally “mischaracterized the authenticity of experiences represented.” 

The four-page commentary, titled “Transactional and transformative diversity, equity, and inclusion activities in health services research departments,” had appeared in the journal Health Services Research for almost three months before its retraction in March. It was co-authored by three employees at the University of Minnesota: professor Janette Dill, lecturer Stuart Grande and Tongtan Chantarat, a research scientist at the institution. 

The article details the DEI-related activities within the school’s Division of Health Policy and Management that were implemented from 2020 onwards amid calls for racial equity. (Minneapolis, where the university’s main campus is based, was the site of George Floyd’s murder in May 2020.) They label some efforts as “performative”, but go on to outline hopes for “transformative change” in the division – referring to attempts to build trust and relationships with students and faculty belonging to racial and ethnic minority groups. 

Mahin Khatami, a former researcher with the U.S. National Institutes of Health who has argued in print that cancer results from ‘dark energy’ and that the government and the pharmaceutical industry are collaborating in ‘scientific/medical Ponzi schemes’ to keep people sick, has lost a paper to retraction.  

As we reported last fall, Robert Speth, a pharmacy science researcher at Nova Southeastern University in Ft. Lauderdale, Fla., has been urging Clinical & Translational Medicine (CTM) to retract Khatami’s articles — and one in particular — for what is now more than two years.

In mid-October a spokesperson for Wiley, which publishes the journal, told us that she was trying to get more information from the editors about why Khatami’s bizarre paper was acceptable material. 

What affects the number of submissions a journal receives? A new study in Learned Publishing, led by staff at Wiley, aimed to find out — and the results, based in part on our database, suggest that retractions may correlate with submission numbers. We asked corresponding author Thomas Gaston to answer a few questions about the paper.

Tell us about your study — why and how you did it, and what you found.